8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Natural Products in Anti-Obesity Therapy

      editorial
      1 , 2 , *
      Molecules
      MDPI

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Obesity is regulated by genetic, endocrine, metabolic, neurological, pharmacological, environmental, and nutritional factors. The brain, gut, and adipose tissues interact with each other through metabolism-related neuropeptides, cytokines, chemokines, adipokines, and gut microbial composition. This contributes to changes in energy intake and energy expenditure. Globally, the increasing incidence of obesity is disturbing. In recent decades, obesity has been recognized as a chronic disease and a serious public health issue. It is well established that obesity causes a lifetime risk of various metabolic disorders such as dyslipidemia, hypertension, type II diabetes mellitus, cardiovascular diseases, and certain types of cancer. These are also associated with hyperglycemia, high cholesterol, insulin resistance, and fatty liver disease. Therefore, early prevention of the occurrence of obesity is necessary. In order to fight obesity, a balanced diet, healthy lifestyle, and pharmacological therapies plus moderate-intensity exercise have been highly praised. Notably, the intake of functional foods is the most ideal treatment modality for weight loss as natural products are non-toxic and healthy. This Special Issue is a collection of seven reviews and seven research articles on the preclinical and clinical benefits of natural products in controlling obesity. The research articles in this issue are broadly divided into four product sources—herbs, fruits, beverages, and trans-fatty acids. Six research articles of this Special Issue focus on evaluating the preventive role and regulated mechanisms of natural products on obesity, insulin resistance, and hepatic steatosis (fatty liver disease). Ansari et al. [1] demonstrated that the detailed molecular mechanisms of Chowiseungcheng-tang (CST), an herbal formulation, are beneficial for anti-obesity by modulating metabolism-related neuropeptides, adipokines, and gut microbial composition. The benefits of other traditional herbal medicines including herbal formula HT048 and Zicao (Lithospermum erythrorhizon) on high-fat diet (HFD)-induced obese rats and spontaneously obese db/db mice was also reported. Lee et al. [2] suggested that HT048 taken as dietary supplement helps to decrease obesity and insulin resistance. Su et al. [3] provided the evidence that the main ingredient of Zicao, Acetylshikonin (AS), exerts anti-obesity and anti-nonalcoholic fatty liver disease (NAFLD) efficacies through the regulation of lipid metabolism and anti-inflammatory effects. In an interesting article, Tung et al. [4] elucidated that piceatannol (3,3’,4,5’-tetrahydroxy-trans-stilbene; Pic), an analogue and metabolite of resveratrol (Res) obtained from red wine, grapes, blueberries, and passion fruits, is shown to decrease lipid accumulation in adipocytes and the liver via the regulation of AMPK expression and gut microbiota. Further, Poncirus trifoliata L. fruit extracts (flavedo (PF) and juice sacs (PJ)) were also found to influence lipid and glucose metabolism and exhibited anti-obesity and hypoglycemic effects [5]. Pu-erh tea, a traditional Chinese beverage, has been believed to have numerous health benefits. This is the reason why Xiao et al. [6] took the advantages of RNA-Seq to determine the gene expression profiling and transcriptional characters of the Pu-erh tea treated C. elegans and found that the vit family is responsive for Pu-erh tea’s function of reducing fat accumulation. However, one of the research articles by Zhao et al. [7] confirms that consumption of a diet high in trans-fatty acids (uncommon in nature) induces higher rates of obesity, insulin resistance (IR), and hepatic steatosis in male C57BL/6 mice, possibly by suppressing the IRS1, diacylglycerol acyl synthetase (DGAT1), adipose triglyceride lipase (ATGL), and acyl-CoA synthetase (ACSL1) dependent pathways. This Special Issue also contains seven review articles that focus on the anti-obesity potential of various tea polyphenols, plant extracts, herbal products, phytochemicals, and tocotrienols on IR which leads to obesity and metabolic complications. The reviews by Pan et al. [8] and Suzuki et al. [9] provide an overview on the recent data highlighting the favorable effects of black tea, green tea, and its catechins in lipid and saccharide digestion, absorption and intake, promotion of lipid metabolism, blockage of the pathological processes of obesity, and comorbidities of obesity by reducing oxidative stress and effects on intestinal microbiota. Two reviews by Avalos-Soriano et al. [10] and Marrelli et al. [11] investigated a detailed account on molecular regulation of the insulinotropic and insulin-sensitizing activity and anti-obesity therapeutic potential by 4-Hydroxyisoleucine (4-OHIle) and saponins isolated from fenugreek (Trigonella foenum-graecum) seeds and medicinal plants. In this Special Issue, two other reviews also summarized the anti-obesity effects of different dietary and herbal natural products, their active ingredients, and anti-adipogenesis mechanisms of action [12,13]. To recognize the physical properties of tocotrienols (T3s) and assess their isomers among T3s potential in regulating obesity, Zhao et al. [14] comprehensively reviewed the scientific literature regarding the impact of T3s on obesity with a particular emphasis on the signaling pathways involved. Overall, we hope this Special Issue will enhance your knowledge of the anti-obesity effects of natural products, provide effective therapeutic strategies, and attract the reader’s interest in developing novel and safe anti-obesity drugs.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity

          Green tea has been shown to have beneficial effects against cancer, obesity, atherosclerosis, diabetes, bacterial and viral infections, and dental caries. The catechin (−)-epigallocatechin-3-gallate (EGCG) has shown the highest biological activity among green tea catechins (GTCs) in most of the studies. While several epidemiological studies have shown the beneficial effects of tea and GTCs on obesity, some studies have failed to do this. In addition, a large number of interventional clinical studies have shown these favorable effects, and cellular and animal experiments have supported those findings, and revealed the underlying anti-obesity mechanisms. One of the mechanisms is enhanced cellular production of reactive oxygen species, which is mediated through the pro-oxidant action of EGCG, leading to the activation of adenosine monophosphate-activated protein kinase, which suppresses gene and protein expression of enzymes and transcription factors involved in adipogenesis and lipogenesis, and stimulates those involved in lipolysis. Recently, scientific evidence supporting the beneficial anti-obesity effects of green tea and GTCs has been increasing. However, future investigations are still required to clarify the reasons for the inconsistent results reported in the human studies; to achieve this, careful adjustment of confounding factors will be required.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Effects of Saponins on Lipid Metabolism: A Review of Potential Health Benefits in the Treatment of Obesity

            Obesity is one of the greatest public health problems. This complex condition has reached epidemic proportions in many parts of the world, and it constitutes a risk factor for several chronic disorders, such as hypertension, cardiovascular diseases and type 2 diabetes. In the last few decades, several studies dealt with the potential effects of natural products as new safe and effective tools for body weight control. Saponins are naturally-occurring surface-active glycosides, mainly produced by plants, whose structure consists of a sugar moiety linked to a hydrophobic aglycone (a steroid or a triterpene). Many pharmacological properties have been reported for these compounds, such as anti-inflammatory, immunostimulant, hypocholesterolemic, hypoglycemic, antifungal and cytotoxic activities. The aim of this review is to provide an overview of recent studies about the anti-obesity therapeutic potential of saponins isolated from medicinal plants. Results on the in vitro and in vivo activity of this class of phytochemicals are here presented and discussed. The most interesting findings about their possible mechanism of action and their potential health benefits in the treatment of obesity are reported, as well.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Piceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice through Modulating Adipogenic Proteins and Gut Microbiota

              Obesity is a global health concern. Piceatannol (Pic), an analog of resveratrol (Res), has many reported biological activities. In this study, we investigated the anti-obesity effect of Pic in a high-fat diet (HFD)-induced obese animal model. The results showed that Pic significantly reduced mouse body weight in a dose-dependent manner without affecting food intake. Serum total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL) levels, and blood glucose (GLU) were significantly lowered in Pic-treated groups. Pic significantly decreased the weight of liver, spleen, perigonadal and retroperitoneal fat compared with the HFD group. Pic significantly reduced the adipocyte cell size of perigonadal fat and decreased the weight of liver. Pic-treated mice showed higher phosphorylated adenosine 5′-monophosphate-activated protein kinase (pAMPK) and phosphorylated acetyl-CoA carboxylase (pACC) protein levels and decreased protein levels of CCAAT/enhancer-binding protein C/EBPα, peroxisome proliferator-activated receptor PPARγ and fatty acid synthase (FAS), resulting in decreased lipid accumulation in adipocytes and the liver. Pic altered the composition of the gut microbiota by increasing Firmicutes and Lactobacillus and decreasing Bacteroidetes compared with the HFD group. Collectively, these results suggest that Pic may be a candidate for obesity treatment.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                20 December 2016
                December 2016
                : 21
                : 12
                : 1750
                Affiliations
                [1 ]Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, via Pietro Bucci, 87036 Arcavacata di Rende (CS), Italy; filomena.conforti@ 123456unical.it
                [2 ]Institute of Food Science and Technology, National Taiwan University, Taipei 10617, Taiwan
                Author notes
                [* ]Correspondence: mhpan@ 123456ntu.edu.tw ; Tel.: +886-2-3366-4133; Fax: +886-2-3366-1771
                Article
                molecules-21-01750
                10.3390/molecules21121750
                6274516
                27999406
                83f9ebc0-7831-47c2-b45e-32fcacb6a672
                © 2016 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 16 December 2016
                : 17 December 2016
                Categories
                Editorial

                Comments

                Comment on this article